VANGUARD GROUP INC - CONMED CORP ownership

CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 156 filers reported holding CONMED CORP in Q2 2016. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of CONMED CORP
ValueSharesWeighting
Q3 2023$346,970,290
-25.8%
3,440,459
-0.0%
0.01%
-18.2%
Q2 2023$467,562,159
+30.4%
3,440,740
-0.4%
0.01%
+22.2%
Q1 2023$358,694,428
+18.2%
3,453,634
+0.9%
0.01%
+12.5%
Q4 2022$303,458,863
+13.4%
3,423,498
+2.5%
0.01%0.0%
Q3 2022$267,654,000
-12.9%
3,338,586
+4.0%
0.01%
-11.1%
Q2 2022$307,459,000
-35.1%
3,210,729
+0.7%
0.01%
-18.2%
Q1 2022$473,678,000
+5.5%
3,188,672
+0.6%
0.01%
+10.0%
Q4 2021$449,187,000
+8.7%
3,168,648
+0.3%
0.01%0.0%
Q3 2021$413,176,000
-4.5%
3,158,108
+0.3%
0.01%
-9.1%
Q2 2021$432,863,000
+6.3%
3,149,699
+1.0%
0.01%0.0%
Q1 2021$407,067,000
+21.1%
3,117,131
+3.8%
0.01%
+10.0%
Q4 2020$336,267,000
+46.3%
3,002,388
+2.8%
0.01%
+25.0%
Q3 2020$229,838,000
+4.9%
2,921,543
-4.0%
0.01%0.0%
Q2 2020$219,087,000
+25.2%
3,043,288
-0.4%
0.01%
+14.3%
Q1 2020$175,047,000
-47.8%
3,056,519
+1.9%
0.01%
-36.4%
Q4 2019$335,501,000
+19.2%
3,000,096
+2.5%
0.01%
+10.0%
Q3 2019$281,410,000
+14.6%
2,926,781
+2.0%
0.01%
+11.1%
Q2 2019$245,554,000
+6.6%
2,869,620
+3.6%
0.01%0.0%
Q1 2019$230,312,000
+30.0%
2,768,841
+0.3%
0.01%
+12.5%
Q4 2018$177,170,000
-16.1%
2,759,658
+3.5%
0.01%0.0%
Q3 2018$211,262,000
+14.8%
2,666,773
+6.1%
0.01%0.0%
Q2 2018$183,980,000
+20.5%
2,513,377
+4.2%
0.01%
+14.3%
Q1 2018$152,722,000
+29.1%
2,411,545
+3.9%
0.01%
+40.0%
Q4 2017$118,291,000
-3.8%
2,320,809
-1.0%
0.01%
-16.7%
Q3 2017$122,973,000
+5.2%
2,343,684
+2.1%
0.01%0.0%
Q2 2017$116,875,000
+16.0%
2,294,366
+1.1%
0.01%
+20.0%
Q1 2017$100,761,000
+4.4%
2,268,882
+3.9%
0.01%0.0%
Q4 2016$96,471,000
+12.9%
2,184,097
+2.4%
0.01%0.0%
Q3 2016$85,452,000
-13.9%
2,133,099
+2.6%
0.01%
-16.7%
Q2 2016$99,207,000
+12.4%
2,078,518
-1.3%
0.01%0.0%
Q1 2016$88,280,000
+6.0%
2,104,909
+11.3%
0.01%0.0%
Q4 2015$83,321,000
-83.2%
1,891,504
-85.0%
0.01%
-66.7%
Q3 2015$494,926,000
+360.2%
12,578,281
+581.4%
0.02%
+157.1%
Q2 2015$107,557,000
+18.9%
1,845,857
+3.0%
0.01%
+16.7%
Q1 2015$90,464,000
+18.5%
1,791,744
+5.5%
0.01%
+20.0%
Q4 2014$76,348,000
+24.7%
1,698,142
+2.2%
0.01%0.0%
Q3 2014$61,207,000
-15.0%
1,661,431
+1.9%
0.01%
-16.7%
Q2 2014$72,007,000
-4.2%
1,630,973
-5.7%
0.01%0.0%
Q1 2014$75,134,000
+5.2%
1,729,200
+2.9%
0.01%0.0%
Q4 2013$71,409,000
+28.7%
1,680,206
+2.9%
0.01%
+20.0%
Q3 2013$55,492,000
+10.2%
1,632,614
+1.3%
0.01%0.0%
Q2 2013$50,351,0001,611,7430.01%
Other shareholders
CONMED CORP shareholders Q2 2016
NameSharesValueWeighting ↓
Endurant Capital Management LP 41,984$4,234,0863.80%
Ranger Investment Management 334,874$33,772,0432.24%
SECTORAL ASSET MANAGEMENT INC 114,000$11,496,9002.24%
EARNEST PARTNERS LLC 2,265,092$228,434,5281.32%
MOUNTAIN PACIFIC INVESTMENT ADVISERS INC/ID 144,376$14,560,3201.01%
EPIQ PARTNERS, LLC 10,463$1,055,1940.80%
Hood River Capital Management LLC 236,127$23,813,4080.76%
Heritage Wealth Partners, LLC 3,375$340,3690.73%
Champlain Investment Partners, LLC 943,260$95,127,7710.62%
WESTWOOD HOLDINGS GROUP INC 559,157$56,3910.53%
View complete list of CONMED CORP shareholders